Vos C M, Westera G
Eur J Nucl Med. 1982;7(2):92-4. doi: 10.1007/BF00251652.
The different forms of 57cobalt-bleomycin (57C0-blm) A2 and B2 as well as 57Co-pepleomycin (57Co-pep), were investigated in tumour-localizing properties of both forms of 57Co-blm are identical if 57Co-blm is injected as a bleomycin solution without carrier cobalt. Differences between the biological behaviour of the various cobalt complexes (which differ in ligand arrangement) were found if these complexes were injected together with inactive cobalt bleomycin complexes of the same form. In this case Co-blm B2 form I and Co-pep form I localize better than Co-blm b2 form II and Co-pep form II respectively. Such a decrease in uptake by the tumour, compared with form I, was not observed for Co-blm A2-II.
对57钴-博来霉素(57C0-blm)A2和B2以及57钴-培普利霉素(57Co-pep)的不同形式进行了研究。如果57Co-blm作为无载体钴的博来霉素溶液注射,则两种形式的57Co-blm在肿瘤定位特性上是相同的。如果将这些配合物与相同形式的无活性钴博来霉素配合物一起注射,则会发现各种钴配合物(其配体排列不同)的生物学行为存在差异。在这种情况下,Co-blm B2形式I和Co-pep形式I的定位分别比Co-blm b2形式II和Co-pep形式II更好。与形式I相比,Co-blm A2-II未观察到肿瘤摄取的这种降低。